共 50 条
- [31] MONITORING NOVEL ANTICOAGULANTS DABIGATRAN, RIVAROXABAN AND APIXABAN USING THROMBELASTOGRAPHYJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A439 - A439Artang, RaminGalloway, GreggNielsen, Joern Dalsgaard
- [32] Drug Interactions of Newer Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban with Routinely Used Nonanticoagulant/Antiplatelet DrugsBLOOD, 2014, 124 (21)Sayani, SherminIqbal, OmerHoppensteadt, DebraFareed, Jawed
- [33] Laboratory Monitoring of Newer Oral Anticoagulants, Rivaroxaban, Apixaban and Dabigatran: Do We Have an Adequate Test?AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S178 - S178Hoppensteadt, DebraWalenga, Jeanine M.Cunanan, JosephineIqbal, OmerLewis, BruceKalodiki, EviKahn, StephenFareed, Jawed
- [34] Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: A retrospective studyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (05) : 967 - 968Antia, CamilaHone, NatalieGloster, Hugh
- [36] Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixabanCLEVELAND CLINIC JOURNAL OF MEDICINE, 2013, 80 (07) : 443 - 451Fawole, AdewaleDaw, Hamed A.Crowther, Mark A.
- [37] Rivaroxaban, dabigatran and apixaban. New anticoagulants in operative urologyUROLOGE, 2014, 53 (06): : 893 - 902John, A.Michel, M. S.
- [39] Adherence to anticoagulant treatment with apixaban and rivaroxaban in a real environmentENFERMERIA CLINICA, 2018, 28 (01): : 63 - 64Romero Arana, Adolfo
- [40] Comparing new oral anticoagulants (dabigatran, rivaroxaban and apixaban) to warfarin in patients with atrial fibrillation, a cost-effectiveness analysis from a German payer perspectiveJOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 256 - 257Krejczy, M.Wehling, M.Marx, S.Obermann, K.Harenberg, J.